Skip to main content
. 2017 Jul 5;313(4):F847–F853. doi: 10.1152/ajprenal.00175.2017

Fig. 4.

Fig. 4.

Twenty-four-hour mean arterial pressure (MAP) measured by telemetry in female SHR treated with control antibody (n = 7; ●) or a monoclonal antibody against TGF-β1,2,3 (n = 8; ○). Data were compared by a repeated-measures ANOVA.